38 related articles for article (PubMed ID: 22037406)
1. Chronic harmine treatment has a delayed effect on mobility in control and socially defeated rats.
Giacobbo BL; Doorduin J; Moraga-Amaro R; Nazario LR; Schildt A; Bromberg E; Dierckx RAJO; de Vries EFJ
Psychopharmacology (Berl); 2020 Jun; 237(6):1595-1606. PubMed ID: 32088835
[TBL] [Abstract][Full Text] [Related]
2. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs.
Conti AC; Cryan JF; Dalvi A; Lucki I; Blendy JA
J Neurosci; 2002 Apr; 22(8):3262-8. PubMed ID: 11943827
[TBL] [Abstract][Full Text] [Related]
3. Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Warren KR; Buchanan RW; Feldman S; Conley RR; Linthicum J; Ball MP; Liu F; McMahon RP; Gorelick DA; Huestis MA; Kelly DL
J Clin Psychopharmacol; 2013 Feb; 33(1):118-20. PubMed ID: 23277241
[No Abstract] [Full Text] [Related]
4. Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease: Two Case Reports.
Först C; Ulrich S; Zurek G; Seifert S; Frank M; Scheidel B
J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):278-283. PubMed ID: 38639428
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of Δ⁹-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression.
Elbatsh MM; Moklas MA; Marsden CA; Kendall DA
Pharmacol Biochem Behav; 2012 Aug; 102(2):357-65. PubMed ID: 22634064
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex.
Yan L; Xu X; He Z; Wang S; Zhao L; Qiu J; Wang D; Gong Z; Qiu X; Huang H
Biomed Res Int; 2020; 2020():2794263. PubMed ID: 32185198
[TBL] [Abstract][Full Text] [Related]
7. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Trefoil Factor 3 Reverses Depressive-Like Behaviors by Activation of BDNF-ERK-CREB Signaling in Olfactory Bulbectomized Rats.
Li J; Luo Y; Zhang R; Shi H; Zhu W; Shi J
Int J Mol Sci; 2015 Nov; 16(12):28386-400. PubMed ID: 26633367
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
Scherma M; Fattore L; Satta V; Businco F; Pigliacampo B; Goldberg SR; Dessi C; Fratta W; Fadda P
Br J Pharmacol; 2013 Jun; 169(4):820-33. PubMed ID: 23072421
[TBL] [Abstract][Full Text] [Related]
10. The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat.
Assareh N; ElBatsh MM; Marsden CA; Kendall DA
Pharmacol Biochem Behav; 2012 Jan; 100(3):506-12. PubMed ID: 22037406
[TBL] [Abstract][Full Text] [Related]
11. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
Ricken R; Ulrich S; Schlattmann P; Adli M
Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
[TBL] [Abstract][Full Text] [Related]
12. Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.
Ward SJ; Raffa RB
Obesity (Silver Spring); 2011 Jul; 19(7):1325-34. PubMed ID: 21475141
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
